To determine if photodynamic therapy with verteporfin (Visudyne; CIBA Vision Corp, Duluth, GA) can improve the chance of stabilizing or improving vision (<8 letter loss) safely in patients with subfoveal choroidal neovascularization (CNV) caused by pathologic myopia.
Titre
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial--VIP report no. 1
Publié dans
Ophthalmology
Volume
108
Numéro
5
Pages
841-52
Date
2001
Editeur
Elsevier
ISSN
0161-6420
Date de création de la notice
2011-02-16